BLACK DIAMOND THERAPEUTICS, INC. Public Float
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Public Float of $113.75 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $113.75M.
- 2024-06-28: Entity Public Float $210.17M.
- 2023-06-30: Entity Public Float $114.54M.
- 2022-06-30: Entity Public Float $55.49M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $113.75M 10-K · filed 2026-03-16 |
| 2024-06-28 | $210.17M 10-K · filed 2025-03-06 |
| 2023-06-30 | $114.54M 10-K · filed 2024-03-12 |
| 2022-06-30 | $55.49M 10-K · filed 2023-03-09 |
| 2021-06-30 | $340.49M 10-K · filed 2022-03-17 |
| 2020-06-30 | $1.01B 10-K · filed 2021-03-25 |
| 2020-02-03 | $910.08M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |